Allergic Reactions to Naprosyn EC
Do not take Naprosyn EC if you are allergic to naproxen or any other ingredient in the medication.
Naprosyn EC belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). These medications help reduce pain, swelling, and inflammation.
Some individuals may experience allergic reactions after taking naproxen or other NSAIDs, including aspirin and ibuprofen.
Symptoms of an allergic reaction may include skin redness, itching, hives, swelling, or difficulty breathing.
Hives, also known as urticaria, are raised, itchy patches that can appear suddenly on the skin.
In severe cases, Naprosyn EC may cause anaphylaxis, a potentially life-threatening allergic reaction.
Symptoms of anaphylaxis may include swelling of the face, lips, tongue, or throat, severe dizziness, wheezing, and difficulty breathing.
Patients who have previously experienced asthma attacks, hives, or other allergic reactions after taking aspirin or another NSAID should not use Naprosyn EC.
Do not take Naprosyn EC if you have a known allergy to naproxen or have experienced an allergic reaction to aspirin or another NSAID. Seek emergency medical attention if you develop breathing difficulties, throat swelling, or signs of anaphylaxis.
Cardiovascular Risks: Heart Attack and Stroke
Naprosyn EC may increase the risk of serious cardiovascular complications, including heart attack and stroke.
NSAIDs can affect blood vessel function, blood pressure, and the body’s natural balance of substances involved in blood clotting.
Although cardiovascular risks vary among individual NSAIDs, naproxen is not completely free of these risks.
The likelihood of complications may increase when the medication is taken at high doses or for extended periods.
Patients with existing cardiovascular conditions may have a higher risk of serious complications.
These conditions include heart disease, hypertension, and high cholesterol.
Other factors, such as smoking, diabetes, obesity, and a previous heart attack or stroke, may also increase cardiovascular risk.
Heart attack symptoms may include chest pain, pressure in the chest, shortness of breath, nausea, or discomfort spreading to the arm, jaw, or back.
Stroke symptoms may include sudden weakness on one side of the body, facial drooping, difficulty speaking, changes in vision, or loss of coordination.
Naprosyn EC should not be used to treat pain around the time of coronary artery bypass graft (CABG) surgery.
Your healthcare provider will evaluate your cardiovascular history before prescribing the medication.
Use Naprosyn EC at the lowest effective dose for the shortest appropriate duration. Seek emergency medical attention if you experience chest pain, sudden weakness, difficulty speaking, or other signs of a heart attack or stroke.
Gastrointestinal Problems: Stomach Ulcers and Bleeding
Naprosyn EC may cause serious gastrointestinal complications, including stomach ulcers, bleeding, and perforation of the stomach or intestines.
A gastrointestinal ulcer is an open sore that develops in the lining of the stomach or upper digestive tract.
A perforation occurs when a hole develops through the wall of the stomach or intestine.
These complications can be life-threatening and may occur without warning symptoms.
Naproxen reduces the production of prostaglandins, which help regulate pain and inflammation.
However, certain prostaglandins also protect the stomach lining from digestive acids.
Reducing these protective substances can make the digestive tract more vulnerable to irritation and injury.
The risk of gastrointestinal complications is higher in older adults and people with a history of stomach ulcers or gastrointestinal bleeding.
Other factors include prolonged NSAID use, high doses, alcohol consumption, smoking, and the use of certain medications.
These medications may include corticosteroids, anticoagulants, aspirin, and some antidepressants.
Taking Naprosyn EC with food or milk may help reduce mild stomach discomfort, but it does not prevent serious ulcers or bleeding.
The enteric coating on Naprosyn EC also does not eliminate these risks.
Warning signs of gastrointestinal bleeding may include black, tarry stools, vomiting blood, vomit resembling coffee grounds, or severe abdominal pain.
Stop taking Naprosyn EC and seek immediate medical attention if you experience signs of gastrointestinal bleeding or severe abdominal pain.
Kidney Problems and Renal Impairment
Naprosyn EC should be used with caution in patients with kidney disease or reduced kidney function.
The kidneys help filter waste products, regulate fluid balance, and maintain normal electrolyte levels in the bloodstream.
Naproxen reduces prostaglandin production, which can affect blood flow to the kidneys.
In some patients, reduced kidney blood flow may lead to worsening kidney function or acute kidney injury.
The risk is higher in patients with existing kidney disease, heart failure, liver disease, or dehydration.
Older adults and patients taking certain blood pressure medications or diuretics may also be more vulnerable.
Signs of kidney problems may include reduced urination, swelling of the feet or ankles, unusual fatigue, or sudden weight gain caused by fluid retention.
However, kidney damage may develop without noticeable symptoms.
Your healthcare provider may recommend blood tests to monitor kidney function if ongoing Naprosyn EC treatment is necessary.
Patients with advanced kidney disease may need to avoid naproxen unless a healthcare provider determines that treatment is appropriate.
Tell your healthcare provider if you have kidney disease, heart failure, or a history of kidney problems before taking Naprosyn EC. Contact your healthcare provider if you notice reduced urination, new swelling, or other symptoms of kidney dysfunction.
Pregnancy and Naprosyn EC
Naprosyn EC should only be used during pregnancy when a healthcare provider determines that treatment is appropriate.
Naproxen belongs to the NSAID class, which can affect fetal development at certain stages of pregnancy.
NSAID use at approximately 20 weeks of pregnancy or later may cause fetal kidney problems and reduce amniotic fluid levels.
Amniotic fluid surrounds and protects the developing baby during pregnancy.
Low amniotic fluid levels may cause complications involving fetal development.
NSAID use at approximately 30 weeks of pregnancy or later may also cause premature closure of the ductus arteriosus, an important blood vessel in the developing baby’s circulation.
For these reasons, naproxen should generally be avoided from 20 weeks of pregnancy onward unless specifically directed by a healthcare provider, and it should be avoided at approximately 30 weeks and later.
If treatment is considered necessary between 20 and 30 weeks, a healthcare provider may recommend the lowest effective dose for the shortest duration and additional fetal monitoring.
Naproxen may also interfere with ovulation and temporarily affect fertility in some women trying to become pregnant.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant. Do not use Naprosyn EC during pregnancy without medical guidance, particularly after 20 weeks.
Breastfeeding and Naprosyn EC
Consult your healthcare provider before taking Naprosyn EC while breastfeeding.
Small amounts of naproxen can pass into human breast milk.
Although the amount transferred is generally low, naproxen remains in the body longer than some other NSAIDs.
This prolonged elimination may increase the potential for medication accumulation in young infants, particularly newborns or premature babies.
For this reason, other pain relievers with shorter elimination times, such as ibuprofen, are often preferred during breastfeeding.
However, the decision depends on your medical condition, treatment needs, and the age and health of your baby.
Your healthcare provider will determine whether naproxen is appropriate or whether another medication would be safer.
If naproxen is prescribed while breastfeeding, your healthcare provider may recommend monitoring the baby for unusual bruising, bleeding, vomiting, or changes in feeding.
Do not start Naprosyn EC while breastfeeding without discussing the potential risks and benefits with your healthcare provider.
Drug Interactions With Naprosyn EC
Naprosyn EC may interact with certain prescription medications, over-the-counter products, and herbal supplements.
Some interactions may increase the risk of gastrointestinal bleeding, kidney problems, or other serious side effects.
For example, taking Naprosyn EC with anticoagulants, also called blood thinners, may increase the risk of bleeding.
These medications include warfarin, apixaban, and rivaroxaban.
Combining naproxen with aspirin or other NSAIDs, such as ibuprofen or diclofenac, may also increase the risk of stomach ulcers and gastrointestinal bleeding.
Naproxen may reduce the effectiveness of certain blood pressure medications, including ACE inhibitors, angiotensin receptor blockers (ARBs), and some diuretics.
When combined with certain medications, Naprosyn EC may also increase the risk of kidney injury.
Other important interactions include lithium and methotrexate.
Naproxen may reduce the elimination of these medications from the body, potentially increasing their concentrations and the risk of toxicity.
Certain antidepressants, including selective serotonin reuptake inhibitors (SSRIs), may further increase the risk of bleeding when used with naproxen.
Your healthcare provider may recommend dosage adjustments, alternative medications, or additional monitoring.
Tell your healthcare provider and pharmacist about all medications and supplements you take before starting Naprosyn EC. Do not combine it with other NSAIDs unless specifically instructed to do so.
Asthma and Aspirin Sensitivity
Patients with asthma should tell their healthcare provider before taking Naprosyn EC.
Asthma is a chronic respiratory condition that causes inflammation and narrowing of the airways.
Symptoms may include wheezing, coughing, chest tightness, and shortness of breath.
Some people with asthma experience worsening respiratory symptoms after taking aspirin or other NSAIDs.
This condition is called NSAID-exacerbated respiratory disease (NERD), sometimes referred to as aspirin-sensitive asthma.
In susceptible individuals, naproxen may trigger bronchospasm, which occurs when the muscles surrounding the airways tighten.
This can cause sudden breathing difficulties or an asthma attack.
People with aspirin-sensitive asthma may also have chronic nasal congestion, sinus problems, or nasal polyps.
Naprosyn EC should not be used by patients who have previously experienced asthma attacks or other hypersensitivity reactions after taking aspirin or another NSAID.
However, not everyone with asthma is sensitive to NSAIDs.
Your healthcare provider will determine whether naproxen is appropriate based on your medical history.
Do not take Naprosyn EC if aspirin or another NSAID has previously triggered an asthma attack. Seek emergency medical attention if you develop severe wheezing or difficulty breathing after taking the medication.
Liver Disease and Liver Damage
Naprosyn EC should be used with caution in patients with liver disease or reduced liver function.
The liver plays an important role in processing medications and removing certain substances from the bloodstream.
Naproxen is metabolized in the liver before being eliminated from the body.
Although serious liver damage from naproxen is uncommon, liver-related adverse effects have been reported.
Some patients may develop elevated liver enzyme levels during treatment.
In rare cases, NSAIDs can cause serious liver injury, including hepatitis or liver failure.
The risk may be greater in patients with existing liver conditions or those taking other medications that affect liver function.
Symptoms of liver problems may include unusual fatigue, persistent nausea, loss of appetite, dark urine, or yellowing of the skin or eyes.
Yellowing of the skin or eyes is called jaundice and may indicate impaired liver function.
Your healthcare provider may recommend liver function tests if you require prolonged Naprosyn EC treatment.
Tell your healthcare provider if you have liver disease before taking Naprosyn EC. Stop taking the medication and seek prompt medical evaluation if you develop jaundice, dark urine, or other signs of liver injury.
Bleeding Disorders and Blood Clotting Problems
Naprosyn EC may increase the risk of bleeding, particularly in patients with existing bleeding disorders.
Naproxen affects platelet function.
Platelets are small blood cells that help form clots to stop bleeding after an injury.
By temporarily reducing platelet aggregation, naproxen may make it more difficult for blood to clot normally.
This effect can become more concerning when the medication is taken alongside anticoagulants, antiplatelet medications, or certain antidepressants.
Patients with conditions such as hemophilia, low platelet counts, or other clotting disorders may have an increased risk of bleeding complications.
Naproxen can also cause bleeding from the stomach or intestines, which may occur without obvious warning symptoms.
Signs of abnormal bleeding may include frequent nosebleeds, unusual bruising, prolonged bleeding from minor cuts, or blood in the urine.
More serious symptoms include vomiting blood, black stools, or unexplained weakness associated with blood loss.
Your healthcare provider may recommend blood tests or additional monitoring if you are at increased risk.
Tell your healthcare provider if you have a bleeding disorder or take blood-thinning medication. Seek immediate medical attention if you experience significant or unexplained bleeding.
Use of Naprosyn EC in Older Adults
Older adults may be more susceptible to certain side effects associated with Naprosyn EC.
As people age, changes in kidney function, cardiovascular health, and the digestive system may affect how the body responds to medications.
Older adults are at greater risk of serious gastrointestinal complications, including stomach ulcers and bleeding.
These complications may occur even when the medication is taken at the recommended dosage.
Age-related reductions in kidney function may also increase the risk of kidney injury.
Older patients are more likely to take several medications, which can increase the possibility of drug interactions.
For example, blood pressure medications, blood thinners, and diuretics may interact with naproxen.
Your healthcare provider may recommend a lower dosage or shorter treatment period to reduce the risk of complications.
Regular monitoring of kidney function, blood pressure, and signs of gastrointestinal bleeding may be necessary during extended treatment.
Older adults should use Naprosyn EC at the lowest effective dose for the shortest medically appropriate duration and report unusual symptoms promptly.
Dizziness, Drowsiness, and Central Nervous System Effects
Naprosyn EC may cause central nervous system (CNS) side effects in some patients.
The central nervous system includes the brain and spinal cord, which control movement, awareness, coordination, and many other body functions.
Commonly reported CNS-related side effects of naproxen include headache, dizziness, and drowsiness.
Some patients may also experience lightheadedness, difficulty concentrating, or a feeling of reduced alertness.
These symptoms may interfere with activities that require attention, coordination, or quick reactions.
Dizziness may also increase the risk of falls, particularly among older adults or patients with balance problems.
If you experience dizziness after taking Naprosyn EC, avoid standing up suddenly and take precautions when walking.
Do not drive, operate heavy machinery, or perform potentially dangerous activities until you know how the medication affects you.
Persistent or severe neurological symptoms should be evaluated by a healthcare provider.
Avoid driving or operating machinery if Naprosyn EC causes dizziness, drowsiness, or impaired concentration. Contact your healthcare provider if these symptoms persist or worsen.
Important Safety Reminders When Taking Naprosyn EC
Naprosyn EC is used to relieve pain, inflammation, and stiffness associated with certain types of arthritis and other inflammatory conditions.
Although it may improve comfort and mobility, it can cause serious side effects, particularly when taken at high doses or for extended periods.
Patients with cardiovascular disease, kidney problems, liver disease, asthma, bleeding disorders, or a history of stomach ulcers should discuss these conditions with their healthcare provider before treatment.
The medication may increase the risk of heart attack, stroke, gastrointestinal bleeding, and kidney injury.
Taking Naprosyn EC with food may help reduce mild stomach irritation, but it does not prevent serious gastrointestinal complications.
Use the lowest effective dose for the shortest duration necessary, and do not combine Naprosyn EC with other NSAIDs without medical advice.
These precautions are not an exhaustive list of all possible warnings, interactions, or side effects. Always follow your healthcare provider’s instructions and attend recommended follow-up appointments if you require ongoing treatment.
REVIEWS